ABSTRACT -We report a case of a 26-year-old man who presented a lower motor neuron syndrome due to hyperparathyroidism. Electromyography showed neurogenic features with normal nerve conduction studies. Hypercalcemia led to the discovery of a primary hyperparathyroidism with gland hyperplasia. Following parathyroid surgery there was recovery of the neurological symptoms.
The neurological clinical syndrome of hyperparathyroidism includes easy fatigability, weakness and especially amyotrophy, of proximal muscles with preserved reflexes in most cases. Neuromuscular symptoms resemble lower motor neuron disord e r s with or without upper motor neuron signs. Neurological complications are common but are minor i n most cases; in some instances, however, they are s o severe as to suggest a primary and even untreatable neurological disorder. Treatable neurological d i sorders mimicking motor neuron disease must be e xcluded and the calcium and phosphorus levels h a v e to be measured since hyperparathyroidism can be cured as in the case we report.
CASE
A 26-year-old caucasian man presented with a oneyear history of symmetric proximal weakness and leg p a i n s , resulting in frequent falls and walking difficulties. He reported difficulty in swallowing, chewing, breathing and speaking. In addition and noted a chest deformity.
Examination revealed a short man with slight proximal muscle atrophy in the upper limbs and proximal e d i stal atrophy in the lower limbs (Fig 1) . There were no fasciculations and both mental status and speech were normal, whilst cranial nerves were intact. Muscle power (according to MRC) was grade 4 in all proximal limbs. The sensory examination was normal. Muscle stretch reflexes were grade 2 in the upper and lower limbs with flexor plantar responses bilaterally. Laboratory studies including routine chemistries, c r eatinephosfokinase and thyroid function were normal. T h e first electrophysiological study (April 2002) showed a neurogenic pattern characterized by polyphasic motor unit potentials with decreased recruitment in several musc l e s of the upper and lower limbs. No fasciculations and fibrillations were seen. Nerve conduction studies were unremarkable. The molecular diagnosis for spinal muscular atrophy (SMA) -(SMN gene) was negative. Five m o n t h s l a t e r, the patient was hospitalized with spontaneous femur fracture. Radiograms of upper and lower extremities showed a diffuse demineralization with areas of subperiosteal resorption. The serum calcium level was 13.5 mg/dl (8.8-10.5), the serum phosphate was 1,6 mg/dl (2,5-4,9), the magnesium was 1,3 mg/dl (1,8-2,4), the serum parathyroid hormone (PTH) was 2018 pg/ml (15-65), the alkaline phosphatase was 1455 mg/dl (50-136) and the 24-hr urinary calcium excretion was 672 mg (42-352). Screening for autoimmune diseases resulted negative. Thyroid ultrasonography revealed increased tracer accumulation in parathyroid topography.
The patient underwent surgery of the parathyroid and the pathology showed diffuse parathyroid hyperplasia (Fig 2) . Subsequently, a progressive recovery of neurological symptoms was observed despite the bone fracture. In June 2003, a new electrophysiological study s h owed a clear improvement in polyphasic motor unit p o t e ntials and decreased recruitment in only the left vastus medial and the tibialis anterior muscles. There was also improvement in calcium, phosphorus and PTH levels.
DISCUSSION
The anatomical localization of the neuromuscular involvement in hyperparathyroidism may be the same as amyotrophic lateral sclerosis (ALS) and S M A 1 . There are few publications on primary hyperparathyroidism resembling SMA or ALS but only 3 with hyperplasia of the parathyroid. The remainder w e r e regarding the adenoma. Most of these cases imp r oved after resection of the parathyroid (Table 1 ).
In our report the hyperparathyroidism was associated with parathyroid hyperplasia. Patten et al. 1 had reported 2 cases of hyperplasia and neuromuscular symptoms but the electrophysiological findings were compatible with myopathy (cases 4 and 6) .In 1984, Patten and Pages 2 reported a case resembling motor neuron disease and hyperplasia of the parathyroid. Patten et al. 1 described 16 cases with neuromuscular symptoms associated with primary hyperparathyroidism and performed muscle biopsy which suggested neurogenic damage in all of them. However, the electrophysiological studi e s had a different pattern 3 and only 6 patients showed lower and/or upper motor neuron signs (Table 1) . In 1988, Verges et al. 4 also described a patient w i t h proximal weakness and quadriceps atrophy associated to parathyroid adenoma.
A clinicopathologic study of an 82-year-old man with progressive spinal muscular atrophy and parathyroid adenoma was reported by Dubas et al. 5 .
Trebini et al. 6 in 1993 published a case on a 57-yearold female, with hyperparathyroidism and motor neuron disease of the spinal muscular atrophy type. Pai et al. 7 in 1997 reported a patient with possible MND who had recovered following parathyroid adenoma resection. However, the electrophysiological findings were not discussed. In 1998, Jackson et a l . 3 reported five patients meeting the El Escorial criteria for ALS and who also had hyperparathyroidism. In none of these cases, however, there was a clinical improvement documented. In 2001, Delmont et a l . 8 described a 72-year-old patient with distal weakness and atrophy of the upper extremities with EM-G showing a lower motor neuron involvement associated with a primary hyperparathyroidism.
Our patient presented electrophysiological and clinical signs of lower motor neuron degeneration resembling a motor neuron disease (MND). Against this diagnosis the calcium level was high and the m a gnesium level was low, the molecular test for SMA w a s A c k n o w l e d g m e n t s -We thank Prof. Mariz Va i n z o f for the study of DNA which searched for a deletion in t h e SMN gene .
